Camber Launches Lidocaine HCl Single-Dose & Multi-Dose Injections
Camber Pharmaceuticals is excited to introduce Lidocaine HCl Injection, USP, in Single-Dose and Multi-Dose Vials. Featuring 1% and 2% concentrations, this versatile product is available in various vial and pack sizes to meet diverse healthcare needs.
Click below to learn more:
Single-Dose Vials: https://www.camberpharma.com/products/lidocaine-sdv/
Multi-Dose Vials: https://www.camberpharma.com/products/lidocaine-mdv/
Camber Pharmaceuticals, a fully integrated pharmaceutical company, is dedicated to delivering high-quality generic medications that enhance lives through cost-effective healthcare solutions. As a subsidiary of Hetero, a global leader in active pharmaceutical ingredients (APIs) and finished dosage manufacturing based in Hyderabad, India, Camber leverages its expertise to ensure access to affordable, reliable pharmaceuticals for consumers worldwide.
Recent articles
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class
- Camber Launches 5 Generics in May






